My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Revista de la OFIL
On-line version ISSN 1699-714XPrint version ISSN 1131-9429
Abstract
PASCUAL-MASIA, L and MARTINEZ-GALAN, F. The future of drug compounding: comments on the Real Decreto 175/2001 modification project. Rev. OFIL·ILAPHAR [online]. 2022, vol.32, n.4, pp.371-374. Epub Oct 23, 2023. ISSN 1699-714X. https://dx.doi.org/10.4321/s1699-714x20220004000010.
Aim:
In March 2022, the Spanish Agency of Medicines and Medical Devices and the Ministry of Health presented for public consultation the project of Real Decreto to modify the RD175/2001, which regulates the compounding of magistral formulas and formulations typified in the National Formulary. This work intends to signify what the new regulation shouldconsider boosting compounding under a higher quality standard.
Method:
Current state of art of compounding in Spain has been studied, just as quality techniques and concepts developed in pharmaceutical industry at an international level.
Results:
Compounding needs to be considered as one between all the activities developed by Pharmacy Services lity assurance to permit a wider classification for the presentations, using resources in a more efficient way and commensurate to the commitment of each Service with compounding.
Conclusion:
Accordingly, the new Real Decreto should acknowledge that the quality of the medicines which reach patients should be the primal objective of this activity.
Keywords : Preparation; quality assurance; regulation; actualization; pharmacy practice.